Catheter Precision (VTAK) Shares Outstanding (Diluted Average) (2021 - 2022)
Catheter Precision (VTAK) reported Shares Outstanding (Diluted Average) of $1.0 million for Q4 2022, up 923.76% year-over-year from $101000.0 in Q4 2021, and up 94588.64% on a QoQ basis from $1092.0 in Q3 2022.
Catheter Precision (VTAK) has 2 years of Shares Outstanding (Diluted Average) data on file, last reported at $1.0 million in Q4 2022.
- Quarterly Shares Outstanding (Diluted Average) rose 923.76% year-over-year to $1.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $1.0 million (up 923.76% YoY) and the FY2022 annual result came in at $1.0 million, up 923.76% from the prior year.
- Shares Outstanding (Diluted Average) rose to $1.0 million in Q4 2022 per VTAK's latest filing, from $1092.0 in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $1.0 million in Q4 2022 and bottomed at $128.0 in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Catheter Precision | 2.01 Mn | 1.20 Mn | 390,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 1,092.00 |
| Dec 31, 2021 | 101,000.00 |
| Sep 30, 2021 | 128.00 |